comparemela.com

Latest Breaking News On - Partner at mission biocapital - Page 1 : comparemela.com

Solve Therapeutics, Inc Acquires Cereius, Inc , a Duke University Spin-Out

Duke University spin-out Cereius is sold to California-based Solve Therapeutics

Cereius, a startup utilizing technology developed at Duke University focusing on radiodiagnostics and radiotherapeutics for use in cancer patients, has been sold. Here are the details.

Mitokinin, Inc , Enters into Purchase Right Agreement with AbbVie

Share this article Share this article SAN FRANCISCO, March 2, 2021 /PRNewswire/  Mitokinin, Inc., a biotechnology company developing PINK1-targeted therapeutics for the treatment of neurodegenerative diseases, announced today that AbbVie, a leading global biopharmaceutical company, has purchased an exclusive right to acquire Mitokinin following completion of IND enabling studies on Mitokinin s lead PINK1 compound. Based on technology discovered at UCSF by Mitokinin co-founders Nicholas Hertz and Kevan Shokat, Mitokinin moved into MBC BioLabs San Francisco in September 2017 with Series A funding from a syndicate led by Mission BioCapital.    Mitokinin s novel PINK1 compounds selectively increase the activity of PINK1, a master regulator of mitochondrial quality control that is genetically linked to Parkinson s disease.  

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.